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Abstract
Background: Nalidixic acid resistance among Salmonella Typhimurium clinical isolates has steadily increased, whereas the
level of ciprofloxacin resistance remains low. The main objective of this study was to characterize the fluoroquinolone
resistance mechanisms acquired in a S. Typhimurium mutant selected with ciprofloxacin from a susceptible isolate and to
investigate its invasion ability.
Methodology/Principal Findings: Three different amino acid substitutions were detected in the quinolone target proteins
of the resistant mutant (MIC of ciprofloxacin, 64 mg/ml): D87G and G81C in GyrA, and a novel mutation, E470K, in ParE. A
protein analysis revealed an increased expression of AcrAB/TolC and decreased expression of OmpC. Sequencing of the
marRAB, soxRS, ramR and acrR operons did not show any mutation and neither did their expression levels in a microarray
analysis. A decreased percentage of invasion ability was detected when compared with the susceptible clinical isolate in a
gentamicin protection assay. The microarray results revealed a decreased expression of genes which play a role during the
invasion process, such as hilA, invF and the flhDC operon. Of note was the impaired growth detected in the resistant strain. A
strain with a reverted phenotype (mainly concerning the resistance phenotype) was obtained from the resistant mutant.
Conclusions/Significance: In conclusion, a possible link between fluoroquinolone resistance and decreased cell invasion
ability may exist explaining the low prevalence of fluoroquinolone-resistant S. Typhimurium clinical isolates. The impaired
growth may appear as a consequence of fluoroquinolone resistance acquisition and down-regulate the expression of the
invasion genes.
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Introduction
Salmonella enterica is a Gram-negative facultative intracellular
anaerobe of worldwide importance causing gastroenteritis in
humans after ingestion of contaminated food or water. Serovars
Enteritidis and Typhimurium are the most frequently isolated
among the more than 2500 serovars characterized in Salmonella
enterica [1,2]. Upon colonization of the intestine by virulent strains,
bacteria localize to the apical epithelium and induce invasion-
associated virulence machinery [2]. Most of these virulence genes
are organized within particular regions of the genome, termed
pathogenicity islands, which are regulated by complex regulatory
networks: the delicate balance of expression of many genes acting
at the correct time in the correct location [3,4]. Thus far, a total of
five Salmonella pathogenicity islands (SPIs) have been described
which are involved in causing disease by allowing invasion of
eukaryotic cells as well as their survival and dissemination within
the organism [3]. Furthermore, SPI-1 [5] and SPI-2 [6] have been
reported to encode the specific machinery that delivers the
effectors into the cytoplasm of the eukaryotic cells; these are the so-
called type 3 secretion systems (T3SS) which play a central role in
the Salmonella-host interaction [7].
Specific antimicrobial therapy is only indicated in the presence
of positive signs of invasive disease, as symptoms usually resolve
spontaneously. However, immunocompromised patients require
treatment to prevent invasion [2,8]. The most appropriate
treatment includes fluoroquinolones, trimethoprim-sulfamethoxa-
zole (TMP-SMZ), ampicillin, or third generation cephalosporins
(ceftriaxone or cefixime). However, since resistance to ampicillin
and TMP-SMZ is common, [1] representing ,57% and ,69% in
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and quinolones seems to be a more reasonable choice when
susceptibilities are unknown.
Nevertheless, quinolone resistance is an emerging problem not
only in clinical strains isolated from humans but also in strains
from livestock [9]. Over the last years several studies, including
unpublished data from the Microbiology Service of our hospital,
have been reported showing an increasing frequency of nalidixic
acid-resistance (MIC.16 mg/mL) linked with a decreased cipro-
floxacin susceptibility level (0.125 mg/mL) [10,11]. In Europe, this
percentage increased from 14% among Salmonella spp. clinical
isolates in 2000, to 20% in 2004. However, ciprofloxacin
resistance (MIC.1 mg/mL) is less frequent, remaining unchanged
at around 0.8% [8,10].
Although plasmid-mediated quinolone resistance has been
described, the main mechanism of acquisition of fluoroquinolone
resistance in Salmonella spp. has been attributed to chromosomal
mutations, such as those characterized within the QRDRs
(quinolone resistance-determining regions) of the target genes
(the gyrA and gyrB genes encoding the A and B subunits of the
DNA gyrase, respectively, and the parC and parE genes encoding
the A and B subunits of the topoisomerase IV, respectively) and
those affecting the accumulation of the antibiotic by decreasing its
uptake as a consequence of a decrease in porin expression or by
increasing the efflux of the drug related to an overexpression of
efflux pump(s) [12–14]. AcrAB/TolC is the main efflux pump
characterized which plays a key role in fluoroquinolone resistance
and in conferring the MAR phenotype [15–18].
According to these clinical data, we hypothesized that
fluoroquinolone resistance may appear concomitantly with a loss
or decrease in expression of virulence factors, such as those that
determine Salmonella invasion ability, leading to an impaired
phenotype unable to adhere to or invade the epithelium in vivo,
and consequently, meaning that these resistant strains would not
be able to adhere to/invade the intestinal epithelia and therefore
they could not be detected as a cause of human disease.
The main objective of this study was to investigate the possible
relationship between quinolone resistance acquisition and expres-
sion of virulence factors. Furthermore, in depth characterization of
the quinolone resistance mechanisms as well as the whole process
of becoming a high-level resistant mutant were also a matter of
concern.
Results
Characteristics of the Resistant Mutants: QRDR Mutations
and Effect of Efflux Pump/s
A high-level ciprofloxacin resistant mutant (strain 50–64, MIC
of 64 mg/mL) was obtained from a Salmonella Typhimurium
clinical isolate which was ciprofloxacin susceptible (strain 50-wt,
MIC of 0.012 mg/mL). In order to study the whole process of
high-level fluoroquinolone resistance acquisition, intermediate
mutants (50-0.007, 50-0.015, 50-0.03, 50-0.6, 50-0.25, 50-2 and
50-16) of this stepwise selection procedure were also included.
Analysis of mutations within the QRDRs of the gyrA, gyrB, parC
and parE genes, as well as evaluation of the MICs of ciprofloxacin,
norfloxacin and nalidixic acid were performed for each selected
strain (Table 1). MICs were further determined in the presence of
20 mg/mL PAbN (Phenyl-Arginine-b-Naphthylamide), an efflux
pump inhibitor. Sequencing results revealed that strain 50–64 had
acquired three different amino acid changes. The first occurred in
GyrA, D87G, of strain 50-0.06. The other two changes appeared at
the same time in strain 50-16, G81C (GyrA) and a non-previously
described mutation at the amino acid codon E470K (ParE).
The resistance profile revealed that strain 50–64 had a 5333-,
5446- and 1024-fold increase in the MICs of ciprofloxacin,
norfloxacin and nalidixic acid, respectively, in comparison to
strain 50-wt (Table 1). Upon the addition of PAbN, only an 83.3-,
170- and 64-fold increase in the MIC of the same antibiotics was
detected when making the same comparison, suggesting that this
partial increment in the resistance phenotype may be attributed to
the QRDR mutations. In addition, these results also indicate that
the remaining increment in resistance (64-, 32- and 128-fold) until
the final MIC values are reached may be attributed to at least one
efflux pump susceptible to this inhibitor.
When taking into account both results, QRDR mutations and
MICs in the presence of PAbN at the same time, a good-
correlation was observed between the largest increments in the
MICs of quinolones between consecutive mutants and the
acquisition of the target gene mutations: strain 50-0.06 (D87G in
Table 1. MIC determinations in the presence and absence of PAbN and mutations detected within the QRDRs.
Strain MIC (mg/mL)
a,b Amino Acid Substitution
c,d
CIP NOR NAL GyrA GyrB ParC ParE
50-wt 0.012 (0.012) 0.094 (0.094) 4 (0.5) --- --- --- --- ---
50-0.007 0.012 (0.012) 0.094 (0.094) 4 (0.5) --- --- --- --- ---
50-0.015 0.032 (0.012) 0.19 (0.125) 8 (0.5) --- --- --- --- ---
50-0.03 0.064 (0.023) 0.5 (0.19) 24 (0.5) --- --- --- --- ---
50-0.06 0.38 (0.19) 3 (2) 256 (8) --- D87G --- --- ---
50-0.25 0.38 (0.19) 3 (2) 256 (8) --- D87G --- --- ---
50-2 1.5 (0.19) 12 (2) 256 (8) --- D87G --- --- ---
50-16 32 (1) 256 (16) 4096 (32) G81C D87G --- --- E470K
50-64 64 (1) 512 (16) 4096 (32) G81C D87G --- --- E470K
50-rev 1.5 (1) 24 (16) 512 (32) G81C D87G --- --- E470K
aCIP, ciprofloxacin; NOR, norfloxacin, NAL, nalidixic acid.
bNumbers in parenthesis represent the MICs determined in the presence of PAbN (20 mg/mL).
c---, no mutation found.
dG, glycine; C, cysteine; D, aspartic acid; E, glutamic acid, K, lysine.
doi:10.1371/journal.pone.0008029.t001
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norfloxacin and nalidixic acid resistances, respectively, in com-
parison with strain 50-0.03, the previous mutant selected; and
strain 50-16 (G81C in GyrA and E470K in ParE) showed a 5.3-,
8- and 4-fold increase in the same MICs in comparison with 50-2,
the previous mutant selected.
On comparing the results obtained from the MICs performed
with and without PAbN, 6 different steps may be taken into
consideration: i) the first step (strain 50-0.015) appears prior to the
acquisition of any QRDR mutation, when the ciprofloxacin
concentration in the media is similar to the MIC of the initial
strain (0.015 mg/mL), and represents a small increase in the MICs
of the three quinolones tested (1.5- to 3-fold). ii) The second step
(strain 50-0.03) mainly represents a further increase in the MIC of
nalidixic acid (3-fold). iii) The third step (strain 50-0.06) is
characterized by the acquisition of the first target gene mutation in
the gyrA gene (D87G) concomitantly with a large increment of the
three MICs (8- to 16-fold in the presence of PAbN). No sign of a
PAbN-susceptible mechanism is detected at this point. iv) The
fourth step (strain 50-2) only affects the MICs of ciprofloxacin and
norfloxacin with a 4-fold increase. v) The fifth step (strain 50-16)
combines, on one hand, two QRDR mutations (in the gyrA (G81C)
and parE (E470K) genes) that can be associated with an increment
of about 4- to 8-fold concerning all the quinolones in the presence
of PAbN. However, with these data, it is not possible to elucidate
the partial contribution of each mutation. On the other hand,
another 2.7- to 4-fold increase in the MIC of the three types of
quinolones used can be attributed to a mechanism susceptible to
the presence of PAbN. Finally, vi) the sixth step (strain 50–64)
shows a 2-fold increase enhancing the MICs of ciprofloxacin and
norfloxacin reaching the maximum values of resistance.
The Quinolone Resistance Phenotype Can Be Partially
Reverted in the Absence of the Antibiotic
In addition to the fluoroquinolone resistant mutants selected in
the presence of ciprofloxacin, strain 50–64 was further examined
to evaluate if a total or partial reversion of the resistance
phenotype could occur under non-selective conditions. Strain
50–64 was grown in the absence of ciprofloxacin 42 consecutive
days and the resulting strain, 50-rev, was characterized. Although
this strain had preserved the same QRDR mutations acquired
previously during the stepwise process, it showed a 43-, 21- and 8-
fold decrease in the MICs of ciprofloxacin, norfloxacin and
nalidixic acid, respectively, in comparison with strain 50–64;
whereas no significant change could be detected in the MICs in
the presence of PAbN (Table 1).
Fluoroquinolone Resistance Associated with the Multiple
Antibiotic Resistance (MAR) Phenotype
Strain 50–64 was analyzed to determine if a MAR phenotype
emerged during the quinolone resistance acquisition process. The
MICs of chloramphenicol, tetracycline, b-lactams (amoxicillin,
ceftriaxone and cefoxitin), erythromycin, kanamycin and trimetho-
primwereassessedandareshowninTable2.Allantibioticsshoweda
significant increase in their MICs when comparing strain 50–64 with
50-wt with the exception of kanamycin. Futhermore, these increasing
values concerning the MAR phenotype, could revert totally or
partially to the wild-type level in strain 50-rev (Table 2).
Sequencing Analysis of Transcriptional Factors Leading
to the MAR Phenotype
Since the MAR phenotype agrees with the substrate profile of
AcrAB [15,19], sequencing of the regulatory loci (acrR, soxRS,
marRAB and ramR) reported to regulate AcrAB expression, as well
as their promoters, was performed in order to detect any possible
mutation that could justify the MAR phenotype (Figure 1).
However, the sequencing results showed that there was no
nucleotide substitution in any of the sequences evaluated.
Bacterial Growth
In order to compare the fitness of strains 50-wt, 50–64 and 50-
rev, growth was measured for each strain. The OD620 was
measured every 15 minutes for 24 hours and the results are shown
in Figure 2. In terms of growth rate (m=(lnN2lnN0)/(t2t0)), a
significant difference between strains 50-wt and 50–64 (P,0.05)
was of note with the latter clearly showing a much longer lag-
phase until the OD significantly increases. Strain 50-rev showed a
lag-phase more similar to that of 50–64 during the first two hours
as well as an intermediate growth rate which was still significantly
different from that of 50-wt (P,0.05) and 50–64 (P,0.05).
However, strain 50-rev eventually reached the same stationary
values than those of 50-wt.
Invasion Assays
A gentamicin protection assay was performed to determine if
there had been any change in the invasion ability of the high-level
resistant mutant (50–64) in comparison with the susceptible isolate,
50-wt. In addition, 50-rev was also tested. Results are expressed as a
percentage of the number of invasive bacteria with respect to the
total number of bacteria present in the initial inoculum. A clear
decrease was observed in the number of bacteria interacting with
the epithelial cells in strain 50–64 with respect to 50-wt when
comparing the images shown in Figure 3. The percentage of
invasion significantly decreased from 11.1% for strain 50-wt to
0.2% for strain 50–64 (P,0.05). However, strain 50-rev only
showed a percentage of 0.7%, a very small increase compared to
that ofthe resistantmutant whichwasnot sufficienttobeconsidered
as a significant reversion (P.0.05). Results are shown in Table 3.
Microarrays I: Evaluating the Resistance Phenotype
A microarray analysis was carried out in order to compare the
differential expression of the genes leading to the observed
phenotype. Two distinct analyses were performed: the first was a
comparison between the levels of expression of strain 50–64 related
to the basal expression of 50-wt. The aim was to determine the
putative genes leading to the high-level fluoroquinolone resistance
phenotype but also to justify the decreased percentage of invasion
ability. The second analysis was a comparison between the levels of
expression of strain 50-rev related to the expression of 50–64 to
detect the genes that could have reverted towards a wild-type
condition. The data from each gene was provided from two
independent experiments. Positive values refer to genes that are up-
Table 2. Characterization of the MAR phenotype.
Strain MIC (mg/mL)
a
CHL TET AMX CRO FOX ERY KAN TMP
50-wt 3 3 6 0.064 3 32 1 0.25
50-64 .256 32 .256 1 .256 .256 1.5 6
50-rev 4 2 8 0.19 6 96 2 1
aCHL chloramphenicol, TET tetracycline, AMX amoxicillin, CRO ceftriaxone, FOX
cefoxitin, ERY erythromycin, KAN kanamycin, TMP trimethoprim.
doi:10.1371/journal.pone.0008029.t002
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(Table 4). Some genes were found to have an impaired expression
linked with their known function in conferring quinolone resistance.
The first analysis showed an increased expression of acrAB (.2-fold)
whereastolC increased butto a lesserextent (1.83/1.06). The second
analysis showed a decrease in the same mRNA transcripts
suggesting a total or partial reversion. The microarray results did
not show any altered expression of any known transcriptional
regulator of AcrAB (acrR, marA, soxS neither ramA) (data not shown).
This result corroborates the fact that no mutation was found within
their regulatory loci as previously mentioned. In addition, a
decreased expression of ompC in the resistant strain was detected
in the first analysis followed by higher levels of expression in the
second. The values for each gene are shown in Table 4.
Microarrays II: Evaluating the Invasion Phenotype
As far as the invasion phenotype is concerned, many genes
showed a decreased expression in strain 50–64 in the first analysis
of the microarrays, and, in addition, most of these showed an
Figure 1. Sequencing map of the known efflux regulators. Schematic representation of the sequences analyzed for detection of mutations
within the regulatory loci operons: acrR (A), soxRS (B), marRAB (C) and ramR (D). Open arrows represent the genes of each operon, dark background
indicates the fragments analyzed. Small black arrows indicate the orientation of the primers. Upper numbers indicate the nucleotide positions of each
gene according to the S. Typhimurium LT2 GenBank Accession No. NC_003197, whereas bold-face numbers indicate the location of the primers.
doi:10.1371/journal.pone.0008029.g001
Figure 2. Bacterial growth. Bacterial growth curves of strains 50-wt,
50–64 and 50-rev are compared. Measures were taken every 15 minutes
for 24 hours from four independent data for each strain. The results are
expressed in a semilogarithmic plot.
doi:10.1371/journal.pone.0008029.g002
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analysis. These affected genes included several operons whose
function has been shown to be important during the invasion
process. In the first analysis, all genes encoded within the SPI-1
showed a decreased expression, including the structural genes
(those encoding the T3SS-1) and primary effectors, encoded in the
prg/org, inv/spa and sic/sip operons, as well as the transcriptional
activators, such as hilA, hilC, hilD and invF. In the second analysis, a
partial increase in their expression was detected (Table 4).
Alternatively, genes belonging to the other SPIs were analyzed
to detect if they could also show an impaired expression. Genes
encoded within SPI-2 [20] and SPI-3 [21] did not show any
significant change in their expression (data not shown). However,
the same was not true concerning the genes encoded within SPI-4
and SPI-5. Intriguingly, when analyzing the six-gene operon
encoded in SPI-4 (siiABCDEF) [22], only the siiB, siiC and siiD
genes showed a significantly decreased expression (2- to 7-fold) (the
siiA gene could not be detected among microarray data, whereas
siiE and siiF did not show any significant change). In addition, the
main operon described in SPI-5, sigDE [23], also showed a
reduced expression, mainly sigD, in 50–64 in comparison with the
susceptible isolate (Table 4). Furthermore, most of the genes
belonging to the operons involved in the synthesis and assembly of
the flagellar apparatus as well as chemotaxis: flg, flj, fli, mot and che
(Table S1), including the regulatory genes flhDC (Table 4),
consistently showed negative values in the first analysis despite
being affected to a different extent. Additionally, positive values
were detected for these genes in the second analysis, albeit no clear
or significant reversion could be concluded.
mRNA Analyses by RT-PCR
The most important genes with a crucial putative role in the
final phenotype were selected to confirm their expression by RT-
PCR (Figure 4). Assays were focused on acrB, tolC and hilA, as the
most significant genes to corroborate results from microarray
analyses. acrB as well as tolC showed an increase in strain 50–64 in
comparison with 50-wt, whereas in 50-rev they decreased to
almost the same levels of expression as 50-wt. By contrast, hilA
showed a substantial decrease in strain 50–64 in comparison with
50-wt, which partially reverted in 50-rev.
Protein Analyses by SDS-PAGE and Western Blotting
A cell envelope protein extract was obtained from strains 50-wt,
50–64 and 50-rev and a sample of each was run in a SDS-PAGE
(Figure 5). The resulting gel confirmed the same expression
pattern observed for acrB, acrA, tolC and ompC mRNAs (results
obtained from both RT-PCR and microarrays analyses). AcrB,
AcrA and TolC proteins showed an increased expression in strain
50–64 in comparison with 50-wt, whereas they showed decreased
levels in 50-rev reaching similar levels to that of 50-wt. In addition,
an inverted effect could be detected for OmpC, showing a
decreased expression in the resistant strain followed by a
consecutive increase in 50-rev.
Furthermore, Western blot detection was performed using
antibodies from rabbit against AcrB and TolC. The same results as
those obtained above were corroborated as is shown in Figure 5.
Discussion
The main purpose of this study has focused on understanding if,
concurrent with the acquisition of fluoroquinolone resistance,
there is a loss or repression of virulence factors, e.g. invasion
proteins. This may explain the clinical scenario in which no
increase in the resistance of Salmonella spp. to ciprofloxacin is
observed whereas resistance to nalidixic has been steadily
increasing. The first objective was to characterize the molecular
mechanisms of fluoroquinolone resistance in a Salmonella Typhi-
murium mutant (strain 50–64, MIC of ciprofloxacin of 64 mg/mL)
obtained in vitro from a highly susceptible clinical isolate (strain 50-
wt, MIC of ciprofloxacin of 0.012 mg/mL) at increasing
concentrations of ciprofloxacin. Intermediate mutants selected
during the resistance stepwise process were also studied.
Comparative study between these strains revealed the acquisi-
tion of three QRDR amino acid changes. The first (A87G in
Figure 3. Cell invasion. Optical microscope images of OHIO cells after an infection of 2.5 hours with strains 50-wt (A) and 50–64 (B). Cells were
stained with Giemsa stain.
doi:10.1371/journal.pone.0008029.g003
Table 3. Percentage of invasion ability.
Strain % Invasion
a
Mean 6SD
b
50-wt 11,1 6,2
50-64 0,2 0,1
50-rev 0,7 0,5
aBacteria surviving treatment with gentamicin as a percentage of total bacteria.
bSD, Standard Deviation of n=3 independent assays.
doi:10.1371/journal.pone.0008029.t003
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(G81C in GyrA and E470K in ParE) were simultaneously
acquired in strain 50-16. Despite mutations in the gyrA and parC
genes being the most commonly found and well-characterized in
conferring quinolone resistance, mutations in the gyrB and parE
genes have also been described, although their contribution, if any,
to the resistance phenotype seems to be lesser [24–27]. Here a
novel mutation in the parE gene is described. Although with the
information reported in this study it is not possible to elucidate the
contribution of this mutation to the resistance phenotype, it may
be important to include not only the gyrB but also the parE genes in
routine sequencing in order to clarify the possible role of these
secondary mutations.
The MICs of quinolones were assessed in the presence of PAbN
and showed evidence of efflux contribution to the resistance
phenotype, ranging from 2.7-fold in strain 50-0.015, to 64-fold in
Table 4. The most significant genes detected in the microarrays results.
Microarray analyses
a,b
Phenotype and gene Product 50–64 vs 50-wt
c 50-rev vs 50–64
d
Resistance phenotype
acrA acridine efflux pump 2.71 2.80 22.51 21.63
acrB acridine efflux pump 2.11 2.51 22.25 21.88
tolC outer membrane channel precursor protein 1.83 1.06 21.35 21.07
ompC outer membrane porin protein C 21.98 21.47 2.34 2.55
Invasion phenotype
SPI-1 hilA invasion protein transcriptional activator 28.54 24.88 1.95 1.57
invF invasion regulatory protein 28.04 24.42 1.41 1.12
hilD invasion regulatory protein 22.42 21.25 1.22 1.19
hilC invasion regulatory protein 25.51 23.01 1.89 1.63
SPI-4 siiB putative methyl-accepting chemotaxis protein 23.76 22.06 1.43 1.34
siiC putative ABC exporter outer membrane component 26.57 23.14 1.25 1.73
siiD membrane permease; HlyD secretion protein 25.56 26.40 1.88 1.87
siiE putative inner membrane protein 21.09 21.25 1.41 1.05
siiF putative ABC-type bacteriocin/lantibiotic exporter 1.12 1.04 1.41 1.04
SPI-5 sigD sopB | secreted effector protein 26.10 23.47 1.69 1.55
sigE pipC | pathogenicity island-encoded protein C 22.83 21.60 1.37 1.07
Flagella flhD transcriptional activator FlhD 22.95 21.63 1.73 2.07
flhC flagellar transcriptional activator 24.19 23.41 2.81 2.07
aeach microarray analysis is provided with two independent data.
b+ indicates up-regulation of the genes, 2 indicates down-regulation.
cgene expression of 50.64 relative to expression of 50.wt.
dgene expression of 50.rev relative to expression of 50.6.
doi:10.1371/journal.pone.0008029.t004
Figure 4. Gene expression analysis by RT-PCR. The RT-PCR assay
performed to detect the levels of expression of the acrB, tolC and hilA
genes. The gapA gene was the internal control used to detect if similar
amounts of RNA were added for each strain assays. Lane 1, strain 50-wt;
lane 2, strain 50–64, lane 3, strain 50-rev.
doi:10.1371/journal.pone.0008029.g004
Figure 5. Protein analysis by SDS-PAGE and Western blot.
Protein analysis was performed using cell envelope protein extracts
loaded in a 12%. SDS-PAGE (A) and Western blot with antibodies
against AcrB and TolC (B). Arrows indicate the specified proteins. Lane 1,
strain 50-wt; lane 2, strain 50–64, lane 3, strain 50-rev.
doi:10.1371/journal.pone.0008029.g005
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ments, such as RT-PCR and protein analyses, revealed the
overexpression of AcrAB/TolC in 50–64. In addition, MICs of
other unrelated drugs, such as b-lactams, chloramphenicol, tetracy-
cline, erythromycin and trimethoprim, were evaluated and showed a
significant increase in 50–64, whereas the resistance to kanamycin
remained unchanged. These results likely encourage the involvement
of AcrAB in the resistance phenotype since this substrate specificity
matches that described for AcrAB/TolC [15,19].
In addition to the resistant mutant, it was possible to obtain a
strain with a reverted phenotype, strain 50-rev, from strain 50–64
which maintained all the QRDR mutations acquired previously
but showed a significant decrease not only in the resistance levels
to the quinolones tested but also to the other unrelated drugs.
Concomitantly, the decrease in AcrAB/TolC expression that was
detected in this strain is noteworthy. To date, this is the first report
showing a partial reversion of the MAR phenotype acquired in vitro
(including the high-level of fluoroquinolone resistance). These
results suggest that a major part of this PAbN-susceptible
mechanism may revert towards a wild-type condition in the
absence of the selective pressure.
Several studies have reported that, in Salmonella spp., the first and
essential step towards the resistance phenotype is the acquisition of
mutationsthat givesrisetoanincreasedefflux,mainlyduetoAcrAB
overexpression, whereas mutations in the QRDRs represent the
second step as well as other mutations enhancing the efflux activity
[16,17,28]. The resistance phenotype observed in this stepwise
process appears as a consequence of progressive increments during
the whole procedure, suggesting that mutations are acquired at
multiple steps. Therefore, we propose that six different steps
occurred on selection with ciprofloxacin. Accordingly, the first step
would be attributed to the implication of an efflux pump, whereas
target gene mutations as well as enhanced efflux activity would be
acquired in the following steps.
AcrAB/TolC overexpression has been reported to increase the
efflux of the three quinolones tested in this study (nalidixic acid,
norfloxacin and ciprofloxacin) [16,29]. However, each of these
steps in which efflux seems to play a role, does not affect all
quinolones in a similar way, as different combinations can be
detected. In agreement with these results, we suggest the
implication of other efflux mechanisms, apart from AcrAB/TolC,
which may each be related to impair quinolone susceptibilities in a
particular way (either nalidixic acid by itself or a combination of
ciprofloxacin and norfloxacin). This suggestion means that
hitherto unknown mechanisms play different roles in the process
of quinolone resistance acquisition. Nevertheless, this is not the
first time that evidence of implication of other efflux pumps, apart
from AcrAB, have been presented [16,17,27]. It has been clearly
demonstrated that a reduced or lack of expression of OmpF is
involved in conferring quinolone resistance [18]. Furthermore,
several studies performed in E. coli also associate a decreased
expression of OmpC with increased resistance to fluoroquinolones
[30,31]; while other studies performed in S. Typhimurium link its
decreased expression with resistance to b-lactams [32,33]. In this
study a decreased OmpC expression was detected in the resistant
mutant. These mechanisms, altogether in combination with
AcrAB/TolC, are likely the explanation for the final phenotype
oberserved. Furthermore, the regulatory protein/s responsible for
the overexpression of these efflux pumps, after showing no
implication of MarA, SoxS and RamA, remain unknown.
However, they also seem to show an impaired expression capable
of reverting in the absence of selective pressure.
The second objective was focused on the characterization of the
invasion phenotype. In order to evaluate the percentage of the
invasion, strains 50-wt, 50–64 and 50-rev were selected to perform
a gentamicin protection assay. The results showed that there was a
significant decrease: from 11.1% in strain 50-wt down to 0.2% in
strain 50–64. However, strain 50-rev still showed a low percentage
(0.7%), meaning that no significant reversion regarding this
phenotype could be concluded. These results are in agreement
with those of the microarrays and RT-PCRs presented above, in
which a significant loss of expression of the operons encoded in
SPI-1, SPI-4 and SPI-5 has been shown in strain 50–64, besides
the slighter repression of those genes encoding flagellar assembly
and function, motility and chemotaxis (flg, flj, fli, flh, mot and che).
Of note was the impaired expression of the key regulators, HilA
and the flhDC operon, respectively. In addition, the lack of a total
recovery of the expression of all these genes in strain 50-rev is
noteworthy and does not allow to consider a significant reversion
either. This full set of genes participates in the first stage of disease
to mediate efficient intestinal colonization and pathogenesis. Thus
a general regulation has been suggested in order to synchronize
their expression [4,34–37]. These results agree with the presence
of a general regulation since they are down-regulated in strain 50–
64 and a partial increased expression is detected in strain 50-rev.
Expression of SPI-1 genes, particularly the main regulator hilA,
is extremely coordinated by many environmental and global
regulatory signals [38,39]. Thus any suboptimal factor, including
growth rate, results in repression of the expression of hilA [38,40]
and the flhDC operon [41]. A link has previously been proposed
between reduced DNA supercoiling (due to the presence of DNA
gyrase inhibitors) and regulation of gene expression [42,43], such
as the proU operon which encodes a glycine betaine transport
system [44] and invasion genes such as invA, encoded within the
SPI-1 [45]. An initial hypothesis to justify the link between
fluoroquinolone resistance and decreased invasion ability suggest-
ed that the mutations acquired in the gyrA gene may be responsible
for a reduced superhelicity causing a repression of these genes.
However, the microarray results did not show any change in the
expression of the proU operon. Furthermore, it has been described
that an Escherichia coli strain with a mutation in the gyrA gene can
still be motile in standard conditions of growth and even in the
presence of low concentrations of a DNA gyrase inhibitor.
Nevertheless, growth was also impaired under the same conditions
that alter motility [46].
More recently, it has been reported that ciprofloxacin-resistant
strains, both clinical isolates and in vitro mutants obtained from
susceptible clinical isolates, showed a decrease in mRNA
expression of invA and avrA genes (the only two SPI-1 genes
tested) in addition to a decrease in cell invasion ability. They also
suggested the possibility that mutations in gyrA may be the cause of
the phenotype. Nevertheless, they observed a decreased growth
rate in ciprofloxacin-resistant strains (MIC of ciprofloxacin
$4 mg/mL) [47]. This particular phenotype was also reported in
a previous study [28] and it was linked to two fluoroquinolone-
resistant mutants obtained in vitro (MICs of ciprofloxacin of 8 and
16 mg/mL). In this study we report a significantly decreased
growth rate in strain 50–64 in comparison to 50-wt. The reverted
strain, 50-rev, showed an impaired growth rate with a longer lag-
phase, more similar to that of 50–64, although it eventually
reached the stationary values of the wild-type strain. Furthermore,
the motility was tested for 50-wt, 50–64 and 50-rev and the results
showed a significant decrease observed in 50–64 which was not
able to revert to the basal motility of 50-wt in 50-rev, being more
similar to that of 50–64 (data not shown).
According to this information and the results presented here, the
most suitable hypothesis found to justify the coexistence of both
phenotypes, fluoroquinolone resistance and decreased invasion
Invasion-Quinolone Resistance
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resistance may alter the growth rate, and it may be the connecting
factor triggering the coordinated repression of the genes implicated
in the invasion phenotype since the optimal environmental
conditions for the expression of these gene is lost, e.g. in 50–64
and 50-rev during the first hours of growth. Next experiments will
be focused on a better understanding of this hypothesis. Further-
more, based on the extensive microarray analyses results, in depth
characterization of the molecular mechanisms leading to the
fluoroquinolone resistancephenotype, suchashitherto effluxpumps
and the regulators that govern their expression as well as expression
of AcrAB, will be studied and characterized.
Materials and Methods
Bacterial Strains and Selection of Resistant Mutants
Strain 50-wt is a Salmonella enterica serovar Typhimurium clinical
isolate recovered from a stool sample in the Department of Clinical
Microbiology in the Hospital Clinic of Barcelona, Spain. A
ciprofloxacin resistant mutant, strain 50–64, was obtained from
50-wt in a multi-step selecting process in the presence of
ciprofloxacin. Strains were grown at 37uC on MacConkey plates.
Ciprofloxacin (Fluka, Steinheim, Germany) was only present during
the selection procedures, starting at 0.007 mg/mL (half of the MIC
for 50-wt) and increasing 2-fold each step, until reaching a
maximum concentration of 64 mg/mL. Single colonies were
selected at each step to be grown at the consecutive ciprofloxacin
concentration and simultaneously a sample was frozen and named
according to the ciprofloxacin concentration of selection (e.g., strain
50-0.007 was selected at a ciprofloxacin concentration of 0.007 mg/
mL). Certain intermediate mutants (50-0.007, 50-0.015, 50-0.03,
50-0.06, 50-0.25, 50-2, 50-16) were chosen during the multi-step
sequential process. Furthermore, a reverted strain, 50-rev, was
selected from 50–64 by growth of single colonies on MacConkey
plates in the absence of ciprofloxacin after 42 consecutive steps.
Susceptibility Testing
MICs of ciprofloxacin, norfloxacin, nalidixic acid, chloram-
phenicol, tetracycline, amoxicillin, erythromycin, kanamycin,
trimethoprim, ceftriaxone and cefoxitin were determined by Etest
(AB Biodisk, Solna, Sweden) according to the manufacturer’s
recommendations. The broth microdilution method was used to
evaluate the MICs of ciprofloxacin, norfloxacin and nalidixic acid
when maximum Etest values were reached. MICs were deter-
mined according to CLSI guidelines [48]. MICs of quinolones
were also determined in the presence of 20 mg/mL of PAbN
(Sigma-Aldrich, St Louis, MD, USA) in MH plates.
Detection of Mutations in the Genes Encoding Quinolone
Protein Targets and Regulatory Loci
Amplification of the QRDRs of gyrA,gyrB,parC,a n dparE,a sw e l la s
the soxRS, marRAB, acrR and ramR regulatory loci (as it is already
known, the transcriptional regulators SoxS, MarA and RamR exert a
positive effect on AcrAB/TolC expression, whereas AcrR is the local
repressor) was performed using the corresponding primers listed in
Table 5. PCR was performed in 50 ml of 1x GoTaq Flexi Buffer with
1.5 mM MgCl2,1 . 5Uo fTaq enzyme (Promega, Madison, WI,
USA), 0.2 mM each deoxynucleoside triphosphate (Invitrogen,
Carlsbad, CA, USA) and 25 pmol each primer (Isogen, De Meern,
The Netherlands), using the following temperature profiles: incuba-
tion at 94uC for 2 min; followed by 94uC for 30 s, 55–62uC for 30–
120 s, and 72uC for 45 s for 30 cycles; with a final extension step of
72uC for 5 min. The appropriate annealing temperature isdetailed in
Table 5. The duration of the extension was 30 s for QRDR
amplification, being 2 min for analyzing the regulatory loci. The
PCR products were loaded in a 1.5% agarose gel, purified using
Wizard SV gel and PCR clean-up system (Promega, Madison, WI,
USA), and sent to Macrogen Inc (Seoul, Korea) for sequencing to
allow comparison with wild-type sequences.
Bacterial Growth
Overnight bacterial cultures grown in LB at 37uC with shaking
of strains 50-wt, 50–64 and 50-rev were diluted to a similar OD
(approximately 0.950 at 620 nm). A 1/100 dilution in fresh LB
broth followed and bacterial growth was allowed at 37uC with
shaking (540 rpm) in sterile 96-well microplates and assessed in an
iEMS Multiskan Reader MF (Thermo Fisher Scientific). OD at
620 nm was determined every 15 minutes for 24 hours. Four
independent assays were performed for each strain and standard
deviation agreed to within 10%.
Cell Envelope Protein Gel Electrophoresis
Bacterial pellets were harvested by centrifugation from 1.5 mL
of an overnight culture grown in LB at 37uC with shaking. Pellets
were rinsed twice with chilled Tris-Mg buffer (10 mM Tris-HCl,
5 mM MgCl2, pH 7.3) and finally resuspended in 1 mL of the
same chilled buffer for sonication (5 cycles of 1 min of sonication
followed by 1 min of rest) (Branson Sonifier 250). These samples
were centrifuged for 2 min at 5,000 rpm, the supernatant was
recovered and centrifuged again at 13,000 rpm for 30 min. Pellets
were finally frozen.
A 12% SDS-polyacrylamide gel electrophoresis was run with
the pellets resuspended in 1x Laemmli buffer. Gel was stained with
Silver Staining Kit, Protein (GE Healthcare, Uppsala, Sweden). In
order to characterize the protein bands of interest, they were
recovered and sent to the Parc Cientific of Barcelona (Barcelona,
Spain), where proteins were digested and sequenced through
MALDI-TOF-TOF analysis.
Adherence and Invasion Assays
Adherence and invasion assays were performed as previously
described [49]. Briefly, monolayers of HeLa Ohio cells (ECACC
84211901) were grown by seeding 35 mm diameter tissue culture
dishes (Corning, Corning, NY) with 5610
5 cells. Plates were
incubated for 24 hours in minimum essential medium (MEM)
(Gibco, Cergy Pontoise, France) supplemented with 10% fetal
bovine serum (Gibco, Cergy Pontoise, France), 1% non-essential
amino acids and 1/100 dilution of penicillin-streptomycin (10000
units-10 mg/mL) (Gibco, Cergy Pontoise, France) in a 5% CO2
atmosphere at 37uC, until a 55% confluency was reached. Cells
were washed three times with MEM and fresh media was added
with heat inactivated fetal bovine serum without antibiotics. Fresh
overnight bacterial cultures incubated in LB at 37uC without
shaking were used to infect each plate at a multiplicity of infection
of 100. Plates were incubated for 2.5 h at 37uC with 5% CO2. For
the adherence assay, infected monolayers were washed, fixed,
stained with Giemsa and observed under a light microscope [49].
For the invasion assay, the infected monolayers were washed 3
times with MEM, fresh complete media containing gentamicin
(100 mg/mL) was added and incubation for an additional 2 h was
performed to kill extracellular bacteria. Monolayers were then
washed 3 times with MEM and 1 mL of cold sterile water was
added to lyse cells for 30 min at 4uC. Samples were pipetted
vigorously and removed, diluted and plated on LB agar plates to
determine the number of CFU (colony forming units) per
monolayer. All experiments were performed at least three
independent times and were carried out in duplicate.
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dilution of an overnight culture grown in LB at 37uCw i t h
shaking, and grown until strains reached the same OD600
values, between 0.5–0.6. Three mL were then taken and treated
with 6 mL of RNAprotect Bacteria Reagent (Qiagen, Hilden,
Germany). Mixtures were processed according to the manufac-
turer’s instructions. Pellets were resuspended in 200 mLo fT E
buffer (10 mM Tris-Cl, 1 mM EDTA and pH 8.0) supplement-
ed with 3 mg/mL lysozyme and vortexed, followed by an
incubation at 32uC for 10 min with shaking. The RNA
extraction was performed using RNeasy Mini Kit
(Qiagen, Hilden, Germany) following the manufacturer’s
recommendations.
Three independent RNA samples of each strain were sent to the
Unidad de Geno ´mica of the Centro Nacional de Biotecnologia
(Madrid, Spain) and processed according to previously described
[50]. Briefly, a 70-mer oligonucleotide microarray constructed
using the genome sequence of S. Typhimurium strain SL1344 was
used for hybridization with the cDNA of each strain. Two separate
experiments were performed. A normalized relative Cy5/Cy3
ratio .2 was considered as a significant increase in expression and
a normalized relative Cy3/Cy5 ratio .2 was considered as a
significant decrease in expression.
RT-PCR
An aliquot of each of the same mRNA extractions used for
microarray analyses was subsequently treated with DNA-free
DNase (Ambion, Austin, TX, USA) according to the manufac-
turer’s recommendations until RNA samples were totally DNA-
free when checked by PCR using gapA (a housekeeping gene)
primers. RT-PCR was performed using the AccessQuick RT-PCR
System (Promega, Madison, WI, USA) and the primers listed in
Table 5. The retrotranscription process was performed using
500 ng of RNA at 45uC for 45 min followed by a normal PCR
program (as previously described), changing the number of cycles
for each amplification as necessary. The annealing temperature
and the number of cycles are detailed in Table 5. Samples were
loaded in a GeneGel Excel (GE Healthcare, Uppsala, Sweden) at
600 V, 25 mA and 15 W for 1.5 h. Gel was stained with a DNA
silver staining kit (GE Healthcare, Uppsala, Sweeden) according to
the manufacturer’s recommendations. Results were corroborated
from two independent mRNA extractions and amplifications.
Western Blotting
Bacterial strains were grown overnight in 50 mL LB at 37uC
with shaking and were harvested by centrifugation. The pellet was
rinsed twice with 10 mM Tris supplemented with 1% NaCl and
Table 5. List of all primers used in this study.
Primer use and gene Primer Sequence 59-39 Product size Temperature (uC) nu of cycles Reference
QRDR
gyrA gyrA.Sal1 AAATCTGCCCGTGTCGTTGGT 344 pb 58uC 30 this study
gyrA.Sal2 GCCATACCTACTGCGATACC
gyrB SgyrB.1 GAATACCTGCTGGAAAACCCAT 446 pb 57uC 30 this study
SgyrB.2 CGGATGTGCGAGCCGTCGACGTCCGC
parC parC.Sal1 AAGCCGGTACAGCGCCGCATC 395 pb 57uC 30 this study
parC.Sal2 GTGGTGCCGTTCAGCAGG
parE SparE.1 CCTGCGGCCCGGCGTTGCCGGGG 465 pb 62uC 30 this study
SparE.2 CGCCCGCCTTCTCTTCTTCCGTCAGCGCG
Regulatory genes
soxRS Ssox.1 GGCACTTTGCGAAGGCGTTACCA 1052 pb 54uC 30 this study
Ssox.2 GGGATAGAGCGAAAGACAA
marRAB Smar.1 AGCGGCGGACTTGTCATAGC 1476 pb 58uC 30 [51]
Smar.2 ACGGTGGTTAGCGGATTGGC
acrR-acrA Sacr.1 CAGTGGTTCCGTTTTTAGTG 1012 pb 58uC 30 [51]
Sacr.2 ACAGAATAGCGACACAGAAA
ramR SramR.1 CGTGTCGATAACCTGAGCGG 933 pb 62uC 30 [52]
SramR.2 AAGGCAGTTCCAGCGCAAAG
RT-PCR
gapA SgapA.RT1 GTATCAACGGTTTTGGCCG 610 pb 58uC 16 this study
SgapA.RT2 GTAGAGGACGGGATGATGTTCT
acrB SacrB.RT1 GCGCGACGTTGATTCCGACTATTG 375 pb 58uC 19 this study
SacrB.RT2 GGATCAGCGCGACCAGCACCGACA
tolC StolC.RT1 TACGCGTTGATGCTGCTGATGGAG 515 pb 58uC 18 this study
StolC.RT2 ACCGCCCGCAACAACCTGGATA
hilA ShilA.RT1 CGCCGGCGAGATTGTGAGTAAAAA 356 pb 58uC 22 this study
ShilA.RT2 TGCGGCAGTTCTTCGTAATGGTCA
doi:10.1371/journal.pone.0008029.t005
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were sonicated on ice on a Vibra-Cell VCX 130 (Sonics) for a total
of 3 min (30 s each cycle of sonication followed by 30 s of rest)
with an amplitude of 50%. Cell debris were removed by
centrifugation for 20 min at 4uC and 3500 rpm whereas the
supernatant was collected and centrifuged again for 90 min at 4uC
and 16000 rpm. The final pellet was resuspended in 1x PBS
(Roche, Mannheim, Germany). Protein quantification was per-
formed using the RC DC Protein Assay kit (Bio-Rad, Hercules,
CA, USA) following the manufacturer’s indications.
Ten mg of each protein sample were loaded in an 8% SDS-
PAGE (Mini Protean II). Transference from gel onto a
nitrocellulose membrane was performed for 2 h at 60 V on ice.
The membranes were blocked using 1x PBS containing Tween 20
diluted 1/2000 (PBS-T) and 5% skim milk for 1 h at RT, followed
by an overnight incubation at 4uC with the primary antibodies
against AcrB and TolC proteins (Antibody Bcn, Barcelona, Spain)
diluted 1/500 into PBS-T. The membranes were washed 3 times
with PBS-T and once with PBS before secondary antibody, anti-
rabbit IgG (GE Healthcare, Buckinghamshire, UK), diluted 1/
2000 in PBS-T, was added for 1 h incubation at RT. The
membranes were washed as previously described and processed
using EZ-ECL (Biological Industries, Kibbutz Beit Haemek, Israel)
for chemiluminescence detection of bands in a Fuji LAS-3000
equipment.
Statistical Analysis
Differences in bacterial growth rate and percentage of invasion
were assessed for significance by using Student’s t-test (Statistical
Package for the Social Sciences, SPSS 18.0). P values less than 0.05
were considered statistically significant at the 95% confidence
interval.
Supporting Information
Table S1 Includes additional data concerning microarray
analysis
Found at: doi:10.1371/journal.pone.0008029.s001 (0.20 MB
DOC)
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